{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:02:31Z","timestamp":1790042551510,"version":"4.0.1"},"reference-count":24,"publisher":"BMJ","issue":"e1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2018,10,9]]},"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1136\/ejhpharm-2018-001695","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T05:39:22Z","timestamp":1542001162000},"page":"e48-e52","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas"],"prefix":"10.1136","volume":"27","author":[{"given":"Guillaume","family":"Le Guyader","sequence":"first","affiliation":[{"name":"Pharmacy Department, Henri Mondor Hospital Group, AP-HP, Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoire","family":"Vieillard","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Henri Mondor Hospital Group, AP-HP, Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Andrieux","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Technologies Chimiques et Biologiques pour la Sant\u00e9 (UTCBS), UMR CNRS 8258 U1022 INSERM, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myl\u00e8ne","family":"Rollo","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Henri Mondor Hospital Group, AP-HP, Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thirion","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Henri Mondor Hospital Group, AP-HP, Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henri Mondor Hospital Group, AP-HP, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Paul","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Henri Mondor Hospital Group, AP-HP, Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,11,10]]},"reference":[{"key":"2025090702475577000_27.e1.e48.1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/pde.12933","article-title":"Effect of angiofibromas on quality of life and access to care in tuberous sclerosis patients and their caregivers","volume":"33","author":"Crall","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"2025090702475577000_27.e1.e48.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712397105"},{"key":"2025090702475577000_27.e1.e48.3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaad.2004.01.009","article-title":"Hamartomas and tubers from defects in hamartin-tuberin","volume":"51","author":"Darling","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2025090702475577000_27.e1.e48.4","doi-asserted-by":"publisher","DOI":"10.2165\/11634580-000000000-00000"},{"key":"2025090702475577000_27.e1.e48.5","first-page":"558","article-title":"Revisi\u00f3n: opciones terap\u00e9uticas actuales para los angiofibromas faciales","volume":"105","author":"Salido-Vallejo","year":"2014","journal-title":"Curr Options Treat Facial Angiofibromas Engl"},{"key":"2025090702475577000_27.e1.e48.6","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.240"},{"key":"2025090702475577000_27.e1.e48.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04212.x"},{"key":"2025090702475577000_27.e1.e48.8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/ajd.12125","article-title":"Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: follow up of a pilot study and promising future directions","volume":"55","author":"Tu","year":"2014","journal-title":"Australas J Dermatol"},{"key":"2025090702475577000_27.e1.e48.9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000489089","article-title":"Comparative effects of topical 0.2% sirolimus for angiofibromas in adults and pediatric patients with tuberous sclerosis complex","volume":"234","author":"Lee","year":"2018","journal-title":"Dermatology"},{"key":"2025090702475577000_27.e1.e48.10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijpharm.2016.05.064","article-title":"Formulation and characterization of a 0.1% rapamycin cream for the treatment of tuberous sclerosis complex-related angiofibromas","volume":"509","author":"Bougu\u00e9on","year":"2016","journal-title":"Int J Pharm"},{"key":"2025090702475577000_27.e1.e48.11","doi-asserted-by":"crossref","unstructured":"Il\u2019ichev YV , Alquier L , Maryanoff CA . Degradation of rapamycin and its ring-opened isomer: role of base catalysis. ARKIVOC 2007:110\u201331.","DOI":"10.3998\/ark.5550190.0008.c09"},{"key":"2025090702475577000_27.e1.e48.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10476.x"},{"key":"2025090702475577000_27.e1.e48.13","doi-asserted-by":"publisher","DOI":"10.1177\/0883073813488664"},{"key":"2025090702475577000_27.e1.e48.14","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.125"},{"key":"2025090702475577000_27.e1.e48.15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2017.04.005","article-title":"Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: a prospective study of 25 patients","volume":"77","author":"Malissen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025090702475577000_27.e1.e48.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2011.00837.x"},{"key":"2025090702475577000_27.e1.e48.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2003.10.025"},{"key":"2025090702475577000_27.e1.e48.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1230416100"},{"key":"2025090702475577000_27.e1.e48.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08643.x"},{"key":"2025090702475577000_27.e1.e48.20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00203614","article-title":"The role of vitamin E in normal and damaged skin","volume":"73","author":"Nachbar","year":"1995","journal-title":"J Mol Med"},{"key":"2025090702475577000_27.e1.e48.21","first-page":"633","article-title":"Urea: A clinically oriented overview from bench to bedside","volume":"15","author":"Friedman","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"2025090702475577000_27.e1.e48.22","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.28.721"},{"key":"2025090702475577000_27.e1.e48.23","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12567"},{"key":"2025090702475577000_27.e1.e48.24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2016.3545","article-title":"Efficacy and safety of topical sirolimus therapy for facial angiofibromas in the tuberous sclerosis complex:\u00a0 a randomized clinical trial","volume":"153","author":"Wataya-Kaneda","year":"2017","journal-title":"JAMA Dermatol"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2018-001695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T09:48:07Z","timestamp":1757238487000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2018-001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,10]]},"references-count":24,"journal-issue":{"issue":"e1","published-online":{"date-parts":[[2020,3,26]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/ejhpharm-2018-001695"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2018-001695","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,10]]}}}